Related Experiment Video
Updated: Sep 15, 2025

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
Published on: February 23, 2015
Females in Psychedelic Research: A Perspective for Advancing Research and Practice.
Zahira Ziva Cohen1,2, Grace Blest-Hopley3
1Medical Research Council - Cognition and Brain Sciences Unit, University of Cambridge, CB2 7EF Cambridge, U.K.
Female ovarian hormones significantly impact psychedelic experiences by altering neurochemistry and cognition. Tracking hormonal fluctuations is crucial for safe, effective psychedelic research and personalized therapy for women.
Area of Science:
- Neuroscience
- Psychopharmacology
- Women's Health
Background:
- Psychedelic research often overlooks the influence of ovarian hormone fluctuations on neurochemistry, cognition, and psychological responses.
- Traditional practices and case studies highlight the importance of considering hormonal factors in psychedelic investigations.
- Current clinical protocols lack sufficient examination of female hormonal impacts on psychedelic effects.
Purpose of the Study:
- To explore the critical intersections between female hormones and psychedelic experiences.
- To inform improved research methodologies and clinical practices in psychedelic science.
- To emphasize the need for understanding female-specific biology in psychedelic pharmacodynamics.
Main Methods:
- Review of existing literature on ovarian hormones, neurochemistry, and psychedelic pharmacology.
- Exploration of the modulatory effects of estradiol (E2) and progesterone (P4) on neurotransmitter systems.
- Analysis of how hormonal fluctuations across the menstrual cycle influence receptor expression and functional connectivity.
Main Results:
- Ovarian hormones modulate key neurotransmitter systems (serotonin, dopamine, GABA, glutamate) involved in psychedelic action.
- Hormonal fluctuations affect interhemispheric communication, synaptic plasticity, mood, cognition, and behavior.
- Menstrual cycle phase influences 5-HT2A receptor expression and functional connectivity, potentially altering psychedelic intensity and efficacy.
Conclusions:
- Female hormonal variability plays a pivotal role in psychedelic experiences, affecting subjective intensity and therapeutic outcomes.
- Incorporating menstrual phase tracking and hormonal assays can reduce data variability and support individualized psychedelic care.
- Improved understanding of female hormonal influences is essential for advancing safe, ethical, and effective psychedelic research and therapies for women.
Related Concept Videos
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Psychedelic Agents
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Socioemotional Experience and Gender Development
Ethics in Research

